IRIS
RUSSO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 461
NA - Nord America 386
AS - Asia 98
AF - Africa 3
SA - Sud America 1
Totale 949
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 385
IE - Irlanda 223
IT - Italia 126
SG - Singapore 51
GB - Regno Unito 30
FR - Francia 26
CN - Cina 24
DE - Germania 22
GR - Grecia 13
FI - Finlandia 8
NL - Olanda 7
KR - Corea 6
HK - Hong Kong 4
TR - Turchia 4
RS - Serbia 3
BD - Bangladesh 2
CD - Congo 2
IN - India 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CA - Canada 1
ID - Indonesia 1
IR - Iran 1
KZ - Kazakistan 1
MD - Moldavia 1
TN - Tunisia 1
VN - Vietnam 1
Totale 949
Salva come PNG Salva come JPEG
Città #
Dublin 223
Santa Clara 46
Ashburn 39
Chandler 37
Singapore 36
Naples 31
Caserta 23
New York 23
Princeton 19
Roxbury 19
Cambridge 17
Bremen 16
Washington 11
Jacksonville 9
Amsterdam 6
Seoul 6
Boardman 5
Jinan 5
Lappeenranta 5
Los Angeles 5
Redwood City 5
Beijing 4
Hong Kong 4
Milan 4
Paris 4
Ariano Irpino 3
Belgrade 3
Des Moines 3
Helsinki 3
Istanbul 3
Wilmington 3
Bonea 2
Chittagong 2
Ercolano 2
Kinshasa 2
Marco 2
Medford 2
Monza 2
Munich 2
Rome 2
Seattle 2
Aci Sant'Antonio 1
Almaty 1
Alpharetta 1
Athens 1
Aydin 1
Bergamo 1
Boydton 1
Buenos Aires 1
Busto Arsizio 1
Casoria 1
Cava de' Tirreni 1
Chisinau 1
Guangzhou 1
Hangzhou 1
Hebei 1
Henderson 1
Ho Chi Minh City 1
Houston 1
Hyderabad 1
Kingston 1
London 1
Miami 1
Morrone 1
Ottaviano 1
Palagiano 1
Perugia 1
Portici 1
Rio Saliceto 1
Salerno 1
San Giorgio a Cremano 1
San Giuseppe Vesuviano 1
San Lazzaro di Savena 1
San Nicola la Strada 1
Shenyang 1
Shijiazhuang 1
Stockholm 1
Tunis 1
Zanjan 1
Totale 678
Salva come PNG Salva come JPEG
Nome #
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 73
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 43
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 40
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 39
Anticoagulant treatment in COVID-19: a narrative review 38
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 38
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 37
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 35
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 34
Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review 33
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 30
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 30
Epidemiological and etiological variations in hepatocellular carcinoma 29
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 27
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 27
Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2 26
Prevalence of occult HBV infection in Western countries 25
Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study 24
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 24
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 23
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 23
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 22
Impact of an education‐based antimicrobial stewardship program on the appropriateness of antibiotic prescribing: Results of a multicenter observational study 22
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 22
Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysis 21
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic 20
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 18
Burden, risk assessment, surveillance and management of SARS-CoV-2 infection in health workers: A scoping review 18
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 18
Current status of laboratory diagnosis for covid-19: A narrative review 17
Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19—An Observational Retrospective Study 13
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 11
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 11
Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens 11
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 10
null 10
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 9
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 8
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 8
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 8
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 6
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 6
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 4
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 4
null 4
The SpO2/FiO2 Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients 3
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 3
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 1
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 1
Totale 1.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.434
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 1 7 7 1 0 2 0
2020/202168 0 0 2 1 12 6 22 11 0 0 12 2
2021/202296 1 4 2 0 27 0 9 2 2 5 4 40
2022/2023356 25 8 6 8 48 30 2 10 186 6 11 16
2023/2024314 20 10 36 30 98 46 4 6 8 6 7 43
2024/2025128 1 11 10 32 74 0 0 0 0 0 0 0
Totale 1.007